Delivery Order SPE2DB22D3401-SPE2DB24FT2LY
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mycophenolate 500 mg tablets. The firm-fixed-price delivery order has a ceiling value of $2,991.75 and a period of performance through April 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award, valued at $2,281.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of Mycophenolate 200 mg/ml suspension, a specialty pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this award is part of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.04 firm fixed-price delivery order is for the supply of MYCOPHENOLATE 500 MG TABLET 500S, a pharmaceutical product. The contract has a performance period extending to July 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,066.66 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of MYCOPHENOLATE 500 MG TABLET 500S, a pharmaceutical product, with a completion date of January 26, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- This federal contract award, with ID SPE2DB25D3201|SPE2DB25FNSRM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,441.56 firm fixed-price delivery order is for the supply of 4,568,038,058 units of the medication Mycophenolate 500 mg Tablet. The contract has an ultimate completion date of April 28, 2025 and does not utilize a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The firm fixed price delivery order, valued at $7,519.74, is for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $10,478.82, is a firm fixed price delivery order for the provision of pharmaceutical products and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,363.17 firm fixed price delivery order contract is for the provision of pharmaceutical products and medical supplies in support of military treatment programs and facilities. Amerisourcebergen Drug Corp serves as the prime contractor, with no set-aside designation...
- The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $1,473.75, is a firm fixed price delivery order for pharmaceutical and medical supply products, awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $10,158.02 firm fixed price delivery order is for the provision of pharmaceutical products and medical supplies in support of military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT2LYDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order, is for the supply of Mycophenolate 500 mg tablets. The contract has a ceiling value of $2,073.55 and a period of performance through April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 4/2/24 |